N.H. U.S. Attorney: Arizona Company and CEO Sentenced for Illegal Distribution of Tianeptine and Other Drugs and Ordered to Forfeit $2.4 Million
February 06, 2024
February 06, 2024
CONCORD, New Hampshire, Feb. 6 -- The office of the U.S. Attorney for the District of New Hampshire issued the following news release on Feb. 5, 2024:
An Arizona company and CEO were sentenced today in federal court in Concord for distributing drugs into interstate commerce, including tianeptine[1], that were not approved by the Food and Drug Administration (FDA), U.S. Attorney Jane E. Young announces.
Centera Bioscience, d/b/a Nootropics Depot, was sentenced by U.S. Ma . . .
An Arizona company and CEO were sentenced today in federal court in Concord for distributing drugs into interstate commerce, including tianeptine[1], that were not approved by the Food and Drug Administration (FDA), U.S. Attorney Jane E. Young announces.
Centera Bioscience, d/b/a Nootropics Depot, was sentenced by U.S. Ma . . .